BTOG 2019 | Lung cancer screening in the UK: CRUK, UK NSC, Public Health England & NHS England
Sara Hiom
Data from the NELSON study (ISRCTN63545820) indicates that lung cancer screening reduces mortality; however, there is not yet a national screening programme in the UK. Here, Sara Hiom, BSc, from Cancer Research UK (CRUK), London, UK, discusses the status and potential implementation of lung cancer screening in the UK, referencing the UK National Screening Committee, Public Health England and NHS England. She highlights the importance of evidence-based decisions and learning from lung health check programmes. This interview took place at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.
Related videos
2:03
TKIs to treat EGFRm-positive NSCLC
Marina Garassino
1:16
The promise of stereotactic radiotherapy for oligometastases
Françoise Mornex
1:50
Prof. Kelly’s overview of the RECaN project
Daniel Kelly
1:03
Managing oligometastatic NSCLC with thoracic irradiation
Françoise Mornex
2:06
Afatinib for advanced EGFRm-positive NSCLC
Antonio Passaro
